Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.23 USD
Change Today -0.07 / -3.04%
Volume 45.4K
BVX On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 2:51 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Snapshot

Open
$2.39
Previous Close
$2.30
Day High
$2.50
Day Low
$2.23
52 Week High
09/8/14 - $4.55
52 Week Low
08/3/15 - $2.06
Market Cap
60.6M
Average Volume 10 Days
15.8K
EPS TTM
$-0.07
Shares Outstanding
27.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BOVIE MEDICAL CORP (BVX)

Related News

No related news articles were found.

bovie medical corp (BVX) Related Businessweek News

No Related Businessweek News Found

bovie medical corp (BVX) Details

Bovie Medical Corporation engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctors’ offices, surgery centers, and hospitals worldwide. The company also develops J-Plasma, a patented plasma-based surgical tool that utilizes a helium ionization process to provide surgeons with greater precision, minimal invasiveness, and an absence of conductive currents during surgery. It leverages its expertise in the design, development, and manufacture of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. The company’s electrosurgical products include desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. In addition, it offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians from a group of specialties, including gynecology, general surgery, and urology. Further, the company provides battery operated cauteries for precise hemostasis in ophthalmology; specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments; and a nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery. It markets its electrosurgical products and technologies through both private labels and own brands, such as Bovie, Aaron, IDS, and ICON to distributors worldwide. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation is headquartered in Clearwater, Florida.

152 Employees
Last Reported Date: 02/27/15

bovie medical corp (BVX) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $525.5K
President, Chief Sales & Marketing Officer an...
Total Annual Compensation: $397.9K
Executive Chairman
Total Annual Compensation: $295.2K
Chief Commercialization Officer
Total Annual Compensation: $302.0K
Senior Vice President
Total Annual Compensation: $283.8K
Compensation as of Fiscal Year 2014.

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Bovie Medical Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported sales of $7,274,000 against $6,945,000 a year ago. Loss from operations was $1,548,000 against $1,746,000 a year ago. Loss before income taxes was $1,497,000 against $332,000 a year ago. Net loss was $1,497,000 or $0.06 per diluted share against net income of $251,000 or $0.07 per diluted share a year ago. Adjusted net loss was $1,587,000 or $0.06 per basic and diluted share against $460,000 or $0.03 per basic and diluted share a year ago. For the six months, the company reported sales of $13,402,000 against $13,427,000 a year ago. Loss from operations was $3,821,000 against $1,687,000 a year ago. Loss before income taxes was $2,367,000 against $9,901,000 a year ago. Net loss was $2,375,000 or $0.41 per diluted share against $9,356,000 or $0.55 per diluted share a year ago. Adjusted net loss was $3,909,000 or $0.18 per basic and diluted share against $536,000 or $0.03 per basic and diluted share a year ago.

Bovie Medical Corporation to Report Q2, 2015 Results on Aug 06, 2015

Bovie Medical Corporation announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Aug 06, 2015

Bovie Medical Corporation, Q2 2015 Earnings Call, Aug 06, 2015

Bovie Medical Corporation, Q2 2015 Earnings Call, Aug 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $2.23 USD -0.07

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IRIDEX Corp $6.80 USD -0.09
MGC Diagnostics Corp $5.06 USD -0.19
Misonix Inc $11.61 USD +0.2448
Stereotaxis Inc $1.50 USD -0.3042
Synergetics USA Inc $4.18 USD -0.17
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings 16.5x
Price/Sales 2.0x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit www.boviemedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.